SONYA TRAMP: Open Payments
NPI 1265023360 · NORTH COLLINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 44 payments from 8 companies in 2025. Trend: 2023 $1,660 · 2024 $369 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $534 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $243 |
| ABBVIE INC. | 11 | $234 |
| Alkermes, Inc. | 8 | $145 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Lundbeck LLC | 4 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: AUSTEDO XR, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, INGREZZA, UZEDY, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
